This inflammatory state activates oncogenic signaling (e.g., NF-κB, STAT3), promotes immune evasion, and provides substrates for tumor metabolic reprogramming, where cancer cells exploit lipids for growth. This evidence concerns the gene NFKB1 and cancer.